Downregulation or loss of E-cadherin expression occurs in a number of cancer types and is thought to play a key role in epithelial-to-mesenchymal transition (EMT) associated with invasive cancer phenotypes (Gregory et al., 2008, Lamouille et al., 2014). The gene discussed is CDH1; the disease is cancer.